Registration of Series D, E, and F Shares with CSDP

Current reports : Current Report No. 2/2025

Date : 07.02.2025

Hour : 15:12

6 February 2025

Subject: Registration of Series D, E, and F Shares with CSDP

Legal basis: Article 56 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies of 29 July 2005

Text of the report:
The Management Board of Diagnostyka S.A. (the “Company”) hereby announces that on 3 February 2025, the Central Securities Depository of Poland (the “CSDP”) registered 17,825,553 ordinary bearer shares in the Company, with a par value of PLN 1.00 each, including:
a. 1,420,700 Series D ordinary bearer shares,
b. 257,729 Series E ordinary bearer shares, and
c. 16,147,124 Series F ordinary bearer shares,
under ISIN PLDGNST00012.

The registration became effective as of 4 February 2025.

The shares referred to above were admitted and introduced to trading on the main market of the Warsaw Stock Exchange (the “WSE”), as announced by the Company in Current Report No. 1/2025 of 6 February 2025.

In addition to the aforementioned ordinary bearer shares, on 3 February 2025, the CSDP registered: (i) 6,372,379 Series A registered shares with voting preference, (ii) 6,372,379 Series B registered shares with voting preference, and (iii) 3,186,189 Series C registered shares with voting preference under ISIN PLDGNST00020. None of these registered shares were submitted for admission or introduction to trading on the regulated market operated by the WSE.

This report was issued by the Company on 6 February 2025, i.e. immediately upon the admission of the Company shares specified above to trading on the regulated market operated by the WSE, which gave rise to the Company’s obligation to publicly disclose current information in compliance with applicable laws and regulations.

Specific legal basis: Section 17.1.1 of the Minister of Finance’s Regulation on current and periodic information to be published by issuers of securities and conditions for recognition as equivalent of information whose disclosure is required under the laws of a non-member state of 29 March 2018

 

For the Company:
Paweł Chytła – Vice President of the Management Board
Jaromir Pelczarski – Vice President of the Management Board

Left arrow icon Return to the For the Investors page